In the ED her vitals were as follows T98 HR 72 BP 157/72 R17 O2sat 96%RA.An NGL was done and cleared after 600cc.
Her Hct on presentation was noted to 37.2, repeated 32.6.
Her INR was 1.1 and PTT 24.1. .
Admitted to [**Hospital Unit Name 153**] for further monitoring.
Family History: noncontributory  Physical Exam: T98.9 HR70 BP135/65 RR20 O2sat 95%RA Gen: NAD, speaking in full sentences HEENT: no conjunctival pallor, MMM dry, OP clear HEART: nl rate, S1S2, no gmr LUNGS: poor insp effort ABD: ostomy bag L mid quadrant surrounded by profound erythematous, eczematous skin changes, mild tenderness to the R of the umbilical region and hypoactive bowel sounds EXT: non-blanching macular-papular rash lower extremities, 2+pitting edema, lanced blister on the plantar surface of the left foot,   Pertinent Results: [**2127-12-6**] 02:30PM BLOOD Lipase-33 [**2127-12-6**] 02:30PM BLOOD ALT-14 AST-20 AlkPhos-51 Amylase-72 TotBili-0.4 [**2127-12-6**] 02:30PM BLOOD Glucose-146* UreaN-13 Creat-1.0 Na-140 K-3.7 Cl-104 HCO3-22 AnGap-18 [**2127-12-16**] 05:50AM BLOOD Glucose-104 UreaN-7 Creat-1.0 Na-137 K-3.7 Cl-102 HCO3-27 AnGap-12 [**2127-12-6**] 08:50PM BLOOD WBC-12.4* RBC-3.76* Hgb-11.4* Hct-32.6* MCV-87 MCH-30.3 MCHC-34.8 RDW-14.4 Plt Ct-452* [**2127-12-16**] 05:50AM BLOOD WBC-5.6 RBC-3.60* Hgb-10.7* Hct-31.3* MCV-87 MCH-29.7 MCHC-34.2 RDW-14.4 Plt Ct-410 .
There are multiple omental metastatic lesions as demonstrated on prior study similar in size.
CT PELVIS WITH IV CONTRAST: The urinary bladder is unremarkable.
IN the ICU, she remained hemodynamically stable with serial HCT checks.
While on the floor she had no further episodes of hematemesis or blood ostomy output.
HCT remained stable.
R sided Hydronephrosis: noted to be stable from prior CT scan.
Medications on Admission: (per [**Company 4916**] Pharmacy, [**Location (un) 3146**]) Advair diskus 500-50 ASA 81 Calcium 600/D one by mouth twice a day Iron 325mg Levoxyl 200mcg Omeprazole 20mg daily Zoloft 50mg daily Ketoconazole topical cream Nystatin   Discharge Medications: 1.
Cholecalciferol (Vitamin D3) 400 unit Tablet Sig: One (1) Tablet PO DAILY (Daily).
Followup Instructions: Provider: [**First Name11 (Name Pattern1) **] [**Last Name (NamePattern1) 593**], MD Phone:[**0-0-**] Date/Time:[**2127-12-30**] 9:30  Provider: [**Name10 (NameIs) **],[**Name11 (NameIs) **] [**Name11 (NameIs) **]/ONCOLOGY-CC9 Date/Time:[**2127-12-30**] 9:30 Provider: [**Name Initial (NameIs) 4426**] 18  Date/Time:[**2127-12-30**] 10:00  [**Last Name (LF) 1576**],[**First Name8 (NamePattern2) 2352**] [**Last Name (NamePattern1) 2352**]-[**Doctor Last Name 1576**] APG (SB) Date/Time:[**2128-1-7**] 11:10  Provider: [**Name10 (NameIs) 1576**],[**First Name8 (NamePattern2) 2352**] [**Doctor Last Name 4694**] APG (SB) Date/Time:[**2128-4-13**] 10:10
